Skip to main content
. Author manuscript; available in PMC: 2011 Jul 1.
Published in final edited form as: Drug Discov Today Dis Mech. 2010 SUMMER;7(2):e109–e115. doi: 10.1016/j.ddmec.2010.07.004

Table 2.

randomized, double blinded, controlled clinical trials for stem cell mobilisation

Trial No. of patients Treatment Follow up (months) Follow up (method) Change in LVEF (%) (Treatment vs. control) p-value
REVIVAL-2 [62] 114 G-CSF 6 MRI 0.5±3.8 vs. 2.0±4.9 NS
STEMMI [63] 78 G-CSF 6 MRI 8.5 vs. 8 NS
G-CSF-STEMI [64] 44 G-CSF 3 MRI 6.2±9.0 vs. 5.3±9.8 NS
Ellis [65] 18 G-CSF 1 ECHO 4.5±11.3/5.2±6.7 vs. 8.0±9.9 NS
HEBE III*[66] EPO 1,5 PVR ongoing --
*

not double blinded;

LVEF = left ventricular ejection fraction;

G-CSF = granulocyte colonie stimulating factor;

EPO = Erythropoietin;

MRI = magnetic resonance imaging;

ECHO = echocardiography;

PVR = planar radionuclide ventriculography

NS = not significant